North America Vision Care Market Analysis and Forecast to 2026 – By FMI

The prevention or minimization of dangers to the eye or visual integrity is defined as vision care. Vision care treats both vision and eye issues, as well as correcting refractive flaws with prescription eyeglasses and contact lenses. With rising technology and a populace addicted to the digital world, quality and quantity of vision care products are projected to increase in the future years.

Substantial investments from market leaders and ongoing research to improve the manufacturing and supply processes of eyeglasses, lenses, and other eye wear are obviously encouraging market sales. In terms of revenue, the North America vision care market is predicted to grow at a CAGR of 9.8% during the forecast period, reaching US$ 100.72 Billion by the end of 2026.

The growing prevalence of chronic diseases, as well as an ageing population prone to eye ailments such as cataracts and glaucoma, are driving growth in the North American vision care industry. The senior population is experiencing a major increase in the prevalence of hyperopia condition. In the United States, around 50% of persons over the age of 65 have hyperopia. Furthermore, favourable reimbursement policies and increased government backing are likely to drive market expansion during the projection period.

Key Players:

Key players in the North America vision care market are Johnson & Johnson Vision Care Inc., Valeant Pharmaceuticals International Inc., Novartis AG, The Cooper Companies Inc., SynergEyes Inc., Luxottica, Essilor International, and ZEISS International. Major players in the market are increasingly entering into mergers and acquisitions to enhance their product portfolio, leverage market opportunities, and increase consumer base.

Key Segment

By Product Type:

  • Rx-Lenses
  • Frames
  • Contact Lenses
  • Non Rx Sunglasses
  • Reading Glasses
  • Contact Lens Solutions

By Distribution Channel:

  • Retail Stores
  • E-Commerce
  • Clinics
  • Hospitals

Get More Insights@ https://www.futuremarketinsights.com/reports/north-america-vision-care-market

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more